Murali Venkatesan in

Murali Venkatesan

Pioneer · DISC type dis
Global Head of Danaher Ventures, Vice President of Business Development, Board Director at Danaher Corporation
📍 San Francisco, California, United States

Murali Venkatesan is the Global Head of Danaher Ventures, where he leads the companys investment strategy in early-stage life sciences and diagnostics. A scientist and inventor with a Ph. D. in Electrical & Computer Engineering from the University of Illinois Urbana-Champaign, he plays a key role in major acquisitions and serves on the board of numerous private companies.

Murali has a deep passion for impacting human health on a global scale. This drives his professional focus and is reflected in his speaking engagements on healthcare transformation, such as his talk at the Global Health Exhibition in Riyadh. He actively mentors young scientists and entrepreneurs, encouraging them to be bold in tackling significant challenges.

He is an inventor on over 20 patents and has co-authored numerous scientific publications, including one detailing a nanopore-based method for DNA methylation detection as a pathway to early cancer detection.

Read the full overview →
Experience
6 Years
Current Role
Global Head of Danaher Ventures, Vice President of Business Development, Board Director
Job Level
Senior
Location
San Francisco, California, United States
Personality Overview

How Murali shows up

Dynamic But Sincere
Driven But Considerate
Decisive But Friendly

They have the unique ability to win both love and respect from their team (or outsiders) They combine a unique set of diverse traits where they are fast and friendly but can slow down to be thorough when needed If they are convinced, they can become very strong champions for your product

Priorities

Topics Murali cares about

Early-Stage Innovation
As Head of Danaher Ventures, he leads strategic investments in early-stage companies, nurturing external innovation to solve critical challenges in healthcare and biology.
Genomic Medicine
His background includes leading teams at Illumina that enabled the $1000 genome and his venture portfolio focuses on transformative platforms for cell and gene therapies.
+5 more topics Login to view topics
Career

Work history

3-2025
Global Head of Danaher Ventures, Vice President of Business Development, Board Director
Danaher Corporation
1-2022 - 9-2025
Head of Danaher Equity Ventures (Americas, Europe) and VP, Science & Technology, Innovation
Danaher Corporation
5-2019 - 1-2022
Vice President, Innovation and Business Development
Danaher Corporation
1-2022
Member Board of Directors
Nuclera
2-2025
Member Board of Directors
Signify Bio
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2021 - 2021
Stanford Executive Program (SEP)
Stanford University Graduate School of Business
2005 - 2011
PhD
University of Illinois Urbana-Champaign
Social presence
in
Behavioral profile

DISC profile (public)

d

Dominance (D)

Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.

Other Danaher Corporation Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Murali. Free, 10 seconds.